Validation of PAG1 as a new risk gene with therapeutic potential for asthma [ 2017 - ]

Research Grant

Researchers: A/Pr Manuel Ferreira (Principal investigator) ,  A/Pr Simon Phipps ,  Dr Antiopi Varelias ,  Prof Philip Thompson

Brief description About 10% of adults and children suffer from asthma in Australia. For >60% of these their asthma symptoms are not well controlled with existing treatments and so novel therapies are needed. We have recently identified PAG1 as a novel risk gene for asthma. In this study, we will conduct mouse and human studies to investigate the possibility inhibition of PAG1 might help prevent or treat asthma exacerbations.

Funding Amount $687,436.00

Funding Scheme Project Grants

Notes Standard Project Grant